Overview

Embryonal Tumor With Multilayered Rosettes

Status:
RECRUITING
Trial end date:
2032-03-31
Target enrollment:
Participant gender:
Summary
This is an open-label, comprehensive, iterative investigation of evaluating the use of induction chemotherapy, high-dose chemotherapy, and focal radiation therapy in children with newly diagnosed Embryonal Tumor With Multilayered Rosettes (ETMR).
Phase:
PHASE2
Details
Lead Sponsor:
University of California, San Francisco
Collaborators:
Pediatric Neuro-Oncology Consortium
Solving Kids' Cancer
Treatments:
Blood Specimen Collection
Drug Therapy
Radiotherapy
Standard of Care
Temozolomide